Our easy-to-read patient fact sheet compares and contrasts sinus arrhythmia vs AFib (atrial fibrillation) symptoms.

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Cough is prevalent in patients with progressive pulmonary fibrosis (PPF) and significantly affects their quality of life.

The FDA has expanded the approval of Xenoview (xenon Xe 129 hyperpolarized) to include use in pediatric patients aged 6 years and older.

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for nasal congestion relief.

Adults seek acute care for moderately severe or uncontrolled asthma due to severe symptoms or the need for quick care after rescue medication.

CHEST’s new practice guidelines on transfusions in critically ill adults promote a more restrictive approach to RBC, FFP, and platelet transfusions.

The VIASKIN peanut patch (VP250) is safe and effective for children aged 1 to 3 years who have peanut allergy, with and without atopic comorbidities.

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are under review.

RSV hospitalization increases the likelihood of cardiovascular events, dysrhythmias or heart failure more than COVID-19 hospitalization.

Lurbinectedin and atezolizumab performed better than atezolizumab alone as maintenance therapy for extensive-stage small cell lung cancer.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®. The new vaccine is indicated for active immunization to prevent COVID-19 caused by SARS ...